This afternoon we watched Intuitive Surgical drop -6.1% to a price of $490.94 per share. The Large-Cap Specialty Industrial Machinery company is now trading -20.78% below its average target price of $619.74. Analysts have set target prices ranging from $350.0 to $700.0 per share for Intuitive Surgical, and have given the stock an average rating of buy.
Intuitive Surgical's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.4%. The stock's short ratio is 2.05. The company's insiders own 0.52% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 89.4%. In conclusion, we believe there is positive market sentiment regarding Intuitive Surgical.
Institutions Invested in Intuitive Surgical
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 9% | 32,212,196 | $15,814,265,413 |
| 2024-12-31 | Blackrock Inc. | 9% | 31,377,331 | $15,404,396,533 |
| 2024-12-31 | State Street Corporation | 4% | 15,305,425 | $7,514,050,057 |
| 2024-12-31 | Price (T.Rowe) Associates Inc | 4% | 14,469,612 | $7,103,715,766 |
| 2024-12-31 | FMR, LLC | 3% | 10,822,224 | $5,313,065,979 |
| 2024-12-31 | JPMORGAN CHASE & CO | 3% | 10,149,035 | $4,982,570,364 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 7,756,727 | $3,808,089,939 |
| 2024-12-31 | Capital World Investors | 2% | 7,426,379 | $3,645,908,790 |
| 2024-12-31 | Morgan Stanley | 2% | 5,817,301 | $2,855,947,542 |
| 2024-12-31 | Bank Of New York Mellon Corporation | 1% | 5,102,587 | $2,505,065,631 |
